Clinical trials of a new recombinant HIV vaccine from Cuba are expected to begin soon, according to Enrique Iglesias, head of the vaccine development team, and Verena Muizo, director of clinical research at the Biotech and Genetic Engineering Center (CIGB), speaking at the International Biotech Conference-Havana 2012, according to AFP and Sky News. The vaccine, TERAVAC-HIV-1, has been tested in mice, and the next step is to carry out a small Phase I trial in HIV-positive people who have not yet progressed to AIDS. The trial is planned for the second or third quarter. Article | Story